SCHEMBL6893089

SCHEMBL6893089

CCC(c1cc[c]cc1)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
PGR P06401 1/20 0.41
CHRM2 P08172 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
AR P10275 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CHRM1 P11229 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
DRD1 P21728 1/20 0.41
TBXA2R P21731 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
CYP2C19 P33261 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10357878 0.79 OPRM1 (0.36) ESR1LMNACYP1A2PGRCHRM2
SCHEMBL598978 0.76 TAAR1 (0.64) ESR1LMNACYP1A2PGRCHRM2
SCHEMBL25334 0.76 ALDH1A1 (0.40) CYP1A2CYP2D6MAPTCYP2C9ALOX15
SCHEMBL23188100 0.74 ESR1 (0.48) ESR1LMNACYP1A2PGRCHRM2
SCHEMBL816075 0.73 ADRA2A (0.42) ESR1LMNACYP1A2PGRCHRM2
SCHEMBL6578290 0.73 CYP17A1 (0.36) ESR1LMNACYP1A2PGRCHRM2
SCHEMBL17084078 0.73 ESR1 (0.46) ESR1LMNACYP1A2PGRCHRM2
SCHEMBL12157071 0.73 ADRB2 (0.48) ESR1LMNACYP1A2PGRCHRM2
SCHEMBL2446248 0.73
SCHEMBL7732261 0.73 ESR1 (0.46) ESR1LMNACYP1A2PGRCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110835332-A Aromatic heterocyclic substituted indazole derivative, preparation method and medical application thereof 浙江海正药业股份有限公司 2020-02-25 CN disclosed
EP-0888262-B1 CYCLOALKYL DERIVATIVES AND THE SOLID-PHASE SYNTHESIS OF SUCH DERIVATIVES BASF AG (DE) 2004-06-02 EP disclosed
CN-1140485-C Cycloalkyl derivatives and solid-phase synthesis thereof BASF 2004-03-03 CN disclosed
CN-1131233-C Carbohydrate derivatives and their solid-phase synthesis BASF AG (DE) 2003-12-17 CN disclosed
US-6521780-B1 Cycloalkylmalonic ester derivatives as potential active substances in the drugs and crop protection; combinatorial chemistry BASF AKTIENGESELLSCHAFT (DE) 2003-02-18 US disclosed
EP-0906324-B1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AG (DE) 2001-08-01 EP disclosed
US-6242583-B1 COUPLING CARBOHYDRATE COMPOUNDS IN PRESENCE OF PROMOTER TO A FUNCTIONALIZED SOLID SUPPORT BASF AKTIENGESELLSCHAFT (DE) 2001-06-05 US disclosed
CN-1219937-A Carbohydrate derivatives and their solid-phase synthesis BASF AG (DE) 1999-06-16 CN disclosed
CN-1218448-A Cycloalkyl derivatives and solid-phase synthesis thereof BASF AG (DE) 1999-06-02 CN disclosed
EP-0888262-A1 CYCLOALKYL DERIVATIVES AND THE SOLID-PHASE SYNTHESIS OF SUCH DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1999-01-07 EP disclosed
WO-1997034852-A1 CYCLOALKYL DERIVATIVES AND THE SOLID-PHASE SYNTHESIS OF SUCH DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1997-09-25 WO disclosed